TransMedics Group, Inc. (TMDX)
113.90
+0.18
(+0.16%)
USD |
NASDAQ |
Mar 20, 16:00
114.50
+0.60
(+0.53%)
After-Hours: 20:00
TransMedics Group Research and Development Expense (Quarterly) : 20.70M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stereotaxis, Inc. | 2.71M |
| CONMED Corp. | 14.90M |
| Dynatronics Corp. | -- |
| Escalon Medical Corp. | 0.1312M |
| IRIDEX Corp. | 0.972M |